Related Experiment Video
Updated: Jul 28, 2025

In vitro Assessment of Aortic Regurgitation Using Four-Dimensional Flow Magnetic Resonance Imaging
Published on: February 25, 2022
Multimodality Quantitative Assessment of Aortic Regurgitation: A Systematic Review
Jacobo Moreno Garijo1, Andrew Roscoe2, Ashley Farrell3
1From the Department of Anesthesiology and Pain Management, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
Abstract:
We performed a systematic review on the agreement and reproducibility of 3 advanced imaging methods, 3-dimensional echocardiography (3DE), cardiac computed tomography (CCT), and cardiac magnetic resonance (CMR), for quantifying aortic regurgitation (AR) severity. Medline, Embase, and Cochrane databases were systematically searched using the PICO model from inception to February 4, 2022, for publications that quantified AR severity with 3DE, CCT, or CMR. Measurement agreement and intraobserver and interobserver reproducibility results were extracted from each study. Study quality was assessed using the QUADAS-2 tool. Forty-two publications with 2176 patients with AR were identified. For 3DE, vena contracta (VC) width, VC area, and effective regurgitant orifice area had higher correlations with AR volume than the 2-dimensional echocardiography (2DE)-derived VC width. CCT-derived regurgitant volume had moderate-to-good correlations with 2DE. CMR regurgitant volume measurements had lower intraobserver and interobserver variabilities because of improved endocardial definition, fewer geometric assumptions, and less angle dependence for flow measurements when compared with 2DE. 3DE color flow convergence methods used to quantify AR severity were superior to 2DE methods and could be used in patients with adequate echocardiographic windows. CCT methods also demonstrated improvements over 2DE methods. Although this method is limited due to the radiation exposure, it could play a role in patients with poor echocardiographic windows unable to tolerate CMR. CMR demonstrated the smallest intraobserver and interobserver variability in evaluating AR severity and is a reasonable option for those where the echocardiographic results are mixed and for clinical trials.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Aortic Regurgitation IV: Nursing Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies

